Adherence to Opioid Patient Prescriber Agreements at a Safety Net Hospital

• Published in: Cancers 2023-05, Vol.15 (11), p.2943
• Main Authors: Pacheco, Soraira, Nguyen, Linh M T, Halphen, John M, Samy, Nikitha N, Wilson, Nathaniel R, Sattler, Gregory, Wing, Shane E, Feng, Christine, Paulino, Rex A D, Shah, Pulin, Addimulam, Supriyanka, Patel, Riddhi, Wray, Curtis J, Arthur, Joseph A, Hui, David
• Format: Article
• Language: English
• Subjects: Age; Alcohol use; Cancer; Cancer patients; Cancer therapies; Care and treatment; Drug use; Ethnicity; Gender; Health surveys; Hispanic people; Hospitals; Marijuana; Medical diagnosis; Narcotics; Oncology, Experimental; Opioids; Pain; Palliation; Palliative care; Palliative treatment; Patient compliance; Patient satisfaction; Patients; Regression analysis; Risk factors; Statistical analysis; Substance abuse treatment; Substance use disorder; Tobacco
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers15112943

Patient prescriber agreements, also known as opioid contracts or opioid treatment agreements, have been recommended as a strategy for mitigating non-medical opioid use (NMOU). The purpose of our study was to characterize the proportion of patients with PPAs, the rate of non-adherence, and clinical predictors for PPA completion and non-adherence. This retrospective study covered consecutive cancer patients seen at a palliative care clinic at a safety net hospital between 1 September 2015 and 31 December 2019. We included patients 18 years or older with cancer diagnoses who received opioids. We collected patient characteristics at consultation and information regarding PPA. The primary purpose was to determine the frequency and predictors of patients with a PPA and non-adherence to PPAs. Descriptive statistics and multivariable logistic regression models were used for the analysis. The survey covered 905 patients having a mean age of 55 (range 18-93), of whom 474 (52%) were female, 423 (47%) were Hispanic, 603 (67%) were single, and 814 (90%) had advanced cancer. Of patients surveyed, 484 (54%) had a PPA, and 50 (10%) of these did not adhere to their PPA. In multivariable analysis, PPAs were associated with younger age (odds ratio [OR] 1.44; = 0.02) and alcohol use (OR 1.72; = 0.01). Non-adherence was associated with males (OR 3.66; = 0.007), being single (OR 12.23; = 0.003), tobacco (OR 3.34; = 0.03) and alcohol use (OR 0.29; = 0.02), contact with persons involved in criminal activity (OR 9.87; < 0.001), use for non-malignant pain (OR 7.45; = 0.006), and higher pain score (OR 1.2; = 0.01). In summary, we found that PPA non-adherence occurred in a substantial minority of patients and was more likely in patients with known NMOU risk factors. These findings underscore the potential role of universal PPAs and systematic screening of NMOU risk factors to streamline care.